ELIQUIS 2.5 mg film-coated tablets

ELIQUIS is an anticoagulant medication co-marketed by Bristol-Myers Squibb and Pfizer, both headquartered in the USA. The manufacturing locations are not specified, but the product is produced in multiple countries. ELIQUIS is used to prevent and treat blood clots in various conditions, including deep vein thrombosis, pulmonary embolism, and stroke prevention in atrial fibrillation patients.